201 related articles for article (PubMed ID: 17119501)
1. [Do cognitive sciences open therapeutic paths in schizophrenia?].
Saoud M; Senn M; Daléry J
Encephale; 2006 Oct; 32(5 Pt 4):S903-6; discussion S907. PubMed ID: 17119501
[No Abstract] [Full Text] [Related]
2. Dissociation of long-term verbal memory and fronto-executive impairment in first-episode psychosis.
Leeson VC; Robbins TW; Franklin C; Harrison M; Harrison I; Ron MA; Barnes TR; Joyce EM
Psychol Med; 2009 Nov; 39(11):1799-808. PubMed ID: 19419594
[TBL] [Abstract][Full Text] [Related]
3. [Functional MRI in schizophrenia. Diagnostics and therapy monitoring of cognitive deficits of schizophrenic patients by functional MRI].
Furtner J; Prayer D; Sachs G
Radiologe; 2010 Feb; 50(2):131-5. PubMed ID: 20076939
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in the effect of repetitive transcranial magnetic stimulation in schizophrenia.
Huber TJ; Schneider U; Rollnik J
Psychiatry Res; 2003 Aug; 120(1):103-5. PubMed ID: 14500119
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment of executive function as a core symptom of schizophrenia.
Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
[TBL] [Abstract][Full Text] [Related]
6. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
Levkovitz Y; Rabany L; Harel EV; Zangen A
Int J Neuropsychopharmacol; 2011 Aug; 14(7):991-6. PubMed ID: 21524336
[TBL] [Abstract][Full Text] [Related]
7. Generalized cognitive dysfunction, symptomatology, and specific cognitive processes in relation to functioning of schizophrenia patients.
Sponheim SR; Surerus-Johnson C; Dieperink ME; Spoont M
Schizophr Res; 2003 Nov; 64(2-3):191-3. PubMed ID: 14613685
[No Abstract] [Full Text] [Related]
8. Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.
Hill SK; Beers SR; Kmiec JA; Keshavan MS; Sweeney JA
Schizophr Res; 2004 Jun; 68(2-3):127-36. PubMed ID: 15099597
[TBL] [Abstract][Full Text] [Related]
9. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study.
Mogg A; Purvis R; Eranti S; Contell F; Taylor JP; Nicholson T; Brown RG; McLoughlin DM
Schizophr Res; 2007 Jul; 93(1-3):221-8. PubMed ID: 17478080
[TBL] [Abstract][Full Text] [Related]
10. Executive functioning component mechanisms and schizophrenia.
Kerns JG; Nuechterlein KH; Braver TS; Barch DM
Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
[TBL] [Abstract][Full Text] [Related]
11. The cognitive neuroscience of memory function and dysfunction in schizophrenia.
Ranganath C; Minzenberg MJ; Ragland JD
Biol Psychiatry; 2008 Jul; 64(1):18-25. PubMed ID: 18495087
[TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits and cognitive training in schizophrenic patients: a review.
Rund BR; Borg NE
Acta Psychiatr Scand; 1999 Aug; 100(2):85-95. PubMed ID: 10480194
[TBL] [Abstract][Full Text] [Related]
13. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia.
Barch DM; Smith E
Biol Psychiatry; 2008 Jul; 64(1):11-7. PubMed ID: 18400207
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive correlates of therapeutic alliance in schizophrenia.
Davis LW; Lysaker PH
J Nerv Ment Dis; 2004 Jul; 192(7):508-10. PubMed ID: 15232322
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.
Granholm E; McQuaid JR; Link PC; Fish S; Patterson T; Jeste DV
Schizophr Res; 2008 Mar; 100(1-3):133-43. PubMed ID: 18222648
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal cortex dysfunction during cognitive tests evidenced by functional near-infrared spectroscopy.
Quaresima V; Giosuè P; Roncone R; Casacchia M; Ferrari M
Psychiatry Res; 2009 Mar; 171(3):252-7. PubMed ID: 19230624
[TBL] [Abstract][Full Text] [Related]
18. Discriminant cognitive factors in responder and non-responder patients with schizophrenia.
Stip E; Lussier I; Ngan E; Mendrek A; Liddle P
Eur Psychiatry; 1999 Dec; 14(8):442-50. PubMed ID: 10683630
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized sham controlled study of deep-TMS add-on treatment for negative symptoms and cognitive deficits in schizophrenia.
Rabany L; Deutsch L; Levkovitz Y
J Psychopharmacol; 2014 Jul; 28(7):686-90. PubMed ID: 24829210
[TBL] [Abstract][Full Text] [Related]
20. Verbal memory in schizophrenia: additional evidence of subtypes having different cognitive deficits.
Bruder GE; Wexler BE; Sage MM; Gil RB; Gorman JM
Schizophr Res; 2004 Jun; 68(2-3):137-47. PubMed ID: 15099598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
